Evolving Spectrum of Antidiabetes Medications
The Evolving Spectrum of Antidiabetes Medications: Practical Perspectives and Clinical Challenges
This educational activity will improve the clinical competence of clinicians to design, initiate, and advance antidiabetes medication treatments to achieve guideline-recommended goals at that key juncture where many of the more traditional treatments are insufficient or undesirable. Key areas of focus include clinician knowledge of the parameters of glycemic control, and in that context, the characteristics of three key therapeutic classes: the DPP-4 inhibitors, the GLP-1 receptor agonists, and the SGLT2 inhibitors. Emphasis will be placed on individualizing treatment design based on the mechanism of action of each class, its benefits, indications and contraindications, utilization in an individualized therapeutic treatment design, and medication titration to achieve goals. Also, in order to support patient achievement of individualized glycemic goals, this education aims to increase awareness of obstacles emanating from patients, as well as from providers and their care delivery systems, in order to identify steps to improve upon them.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Live Online Activity: Thursday, October 6, 2016 from 12:00PM – 1:00PM EST.
Primary Care Network designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Online On-Demand Enduring Material
Primary Care Network designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The enduring material will be available from October 6, 2016 – April 6, 2017.
The ACCME (Accreditation Council for Continuing Medical Education) and the American Board of Internal Medicine (ABIM) have collaborated to simplify the integration of Maintenance of Certification (MOC) and accredited CME. This collaboration expands the number and diversity of accredited CME activities registered in ABIM’s MOC program, offering ABIM Board Certified physicians more options for receiving MOC points through their participation in CME activities.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Upon completion, your information will be shared with ABIM through Primary Care Network’s ACCME Program and Activity Reporting System (PARS).
At the conclusion of this activity, participants will be able to:
- Describe how consideration of the pathophysiology of type 2 diabetes, as well as the mechanisms of action of antidiabetes drug classes, can be used to design individualized treatment programs for type 2 diabetes
- Summarize usage parameters for key newer antidiabetes medications, including indications, contraindications, potential adverse effects, and initiation/titration methodology
- Discuss assessment of A1C and glycemic patterns as therapeutic targets and the monitoring for adverse events as a consideration in the advancement of antidiabetes medication therapies
Jointly provided by Primary Care Network and PlatformQ Health Education, LLC.
Participant will need to initially complete a short registration form with Diabetes Series Live to participate in this activity. Future participation in Diabetes Series Live activities will allow you to skip the registration process and only require you to log-in.
Published September 6, 2016